ImmuONE

📍 Stevenage, United Kingdom🗓 Founded 2019👥 21 employees💰 Last funded Oct 2023
Biotechnology🌐 immuone.com
Website LinkedIn
ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results.   ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models.   We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs.    We invite you to learn more about how our products and services can help your business by visiting our website: www.immuone.com   Follow us on Twitter: @ImmuONE
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in ImmuONE?
ImmuONE has 1 investors on record on gritt.io, 1 mid-stage.
When did ImmuONE last raise funding?
The most recent investment in ImmuONE recorded on gritt.io was in October 2023.
When was ImmuONE founded?
ImmuONE was founded in 2019.
What industry is ImmuONE in?
ImmuONE operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ImmuONE based?
ImmuONE is headquartered in Stevenage, United Kingdom.